Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC2 receptor for vasoactive intestinal peptide

被引:112
作者
Goetzl, EJ
Voice, JK
Shen, SB
Dorsam, G
Kong, Y
West, KM
Morrison, CF
Harmar, AJ
机构
[1] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Med Ctr, Dept Immunol, San Francisco, CA 94143 USA
[3] Univ Edinburgh, Dept Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland
关键词
immunity; T cell; neuropeptide; cytokine; IgE;
D O I
10.1073/pnas.241503798
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Vasoactive intestinal peptide (VIP) and its G protein-coupled receptors, VPAC(1)R and VPAC(2)R, are prominent in the immune system and regulate many aspects of T cell-dependent immunity. In mouse T cells, VPAC(1)R is expressed constitutively, whereas VPAC(2)R is induced by immune stimuli. VPAC(2)R-null (VPAC(2)R(-/-)) mice on a C57BL/6 background are shown here to have normal basic immune characteristics, including serum Ig concentrations, blood levels of all leukocytes, and spleen number of total T cells (CD3(+)) and T cells bearing CD4, CD8, and CD28. Hapten-evoked cutaneous delayed-type hypersensitivity (DTH) was significantly enhanced in VPAC(2)R-null mice compared with age- and sex-matched wild-type mice. In contrast, generation of IgE anti-hapten antibodies and active cutaneous anaphylaxis were greater than or equal to 70% lower in VPAC(2)R-null mice than in wild-type controls. Cytokine production by splenic CD4(+) T cells, stimulated with adherent anti-CD3 plus anti-CD28 antibodies, revealed higher levels of IL-2 (mean = 3-fold) and IFN-gamma (mean = 3-fold), and lower levels of IL-4 (mean = one-fifth) in VPAC(2)R-null mice than wild-type controls. Loss of VIP-VPAC(2)R maintenance of the normal ratio of Th2/Th1 cytokines thus leads to a state of enhanced DTH and depressed immediate-type hypersensitivity, which may alter both host defense and susceptibility to immune-mediated diseases.
引用
收藏
页码:13854 / 13859
页数:6
相关论文
共 30 条
  • [1] The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation
    Bellinger, DL
    Lorton, D
    Brouxhon, S
    Felten, S
    Felten, DL
    [J]. ADVANCES IN NEUROIMMUNOLOGY, 1996, 6 (01): : 5 - 27
  • [2] Vasoactive intestinal peptide in thymus: Synthesis, receptors and biological actions
    Delgado, M
    Martinez, C
    Leceta, J
    Gomariz, RP
    [J]. NEUROIMMUNOMODULATION, 1999, 6 (1-2) : 97 - 107
  • [3] Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes
    Delgado, M
    Martinez, C
    Johnson, MC
    Gomariz, RP
    Ganea, D
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1996, 68 (1-2) : 27 - 38
  • [4] Cutting edge: Is vasoactive intestinal peptide a type 2 cytokine?
    Delgado, M
    Ganea, D
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (05) : 2907 - 2912
  • [5] DORSAM G, 2001, ANN NY ACAD SCI, V952, P79
  • [6] Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs
    Ganea, D
    [J]. ADVANCES IN NEUROIMMUNOLOGY, 1996, 6 (01): : 61 - 74
  • [7] Goetzl EJ, 1996, J IMMUNOL, V156, P1
  • [8] SPECIFIC RECOGNITION OF THE HUMAN NEUROENDOCRINE RECEPTOR FOR VASOACTIVE-INTESTINAL-PEPTIDE BY ANTIPEPTIDE ANTIBODIES
    GOETZL, EJ
    PATEL, DR
    KISHIYAMA, JL
    SMOLL, AC
    TURCK, CW
    LAW, NM
    ROSENZWEIG, SA
    SREEDHARAN, SP
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 1994, 5 (02) : 145 - 152
  • [9] VASOACTIVE-INTESTINAL-PEPTIDE (VIP) MESSENGER-RNA EXPRESSION IN RAT T-LYMPHOCYTES AND B-LYMPHOCYTES
    GOMARIZ, RP
    LECETA, J
    GARRIDO, E
    GARRIDO, T
    DELGADO, M
    [J]. REGULATORY PEPTIDES, 1994, 50 (02) : 177 - 184
  • [10] Development of high affinity selective VIP1 receptor agonists
    Gourlet, P
    Vandermeers, A
    Vertongen, P
    Rathe, J
    De Neef, P
    Cnudde, J
    Waelbroeck, M
    Robberecht, P
    [J]. PEPTIDES, 1997, 18 (10) : 1539 - 1545